2,6-Pyridodicarboxamide-Bridged Triptycene Molecular Transmission Devices: Converting Rotation to Rocking Vibration by Guangxia Wang (1478734)

“…A series of <i>N</i>²,<i>N</i>⁶-bis­(triptycene-9-yl)­pyridine-2,6-dicarboxamides <b>1</b>–<b>4</b> were designed and synthesized. …”

2,6-Pyridodicarboxamide-Bridged Triptycene Molecular Transmission Devices: Converting Rotation to Rocking Vibration by Guangxia Wang (1478734)

“…A series of <i>N</i>²,<i>N</i>⁶-bis­(triptycene-9-yl)­pyridine-2,6-dicarboxamides <b>1</b>–<b>4</b> were designed and synthesized. …”

Table_5_In vitro Neuroprotective Potential and Lipidomics Study of Olive Leaves Extracts Enriched in Triterpenoids.XLSX by Rocío Gallego (9723148)

“…Moreover, several triacylglycerols were found decreased. These results suggest triterpenoids from olive leaves as good neuroprotective candidates, and open a new gate for future experiments using in vivo models to corroborate this hypothesis.…”

2,6-Pyridodicarboxamide-Bridged Triptycene Molecular Transmission Devices: Converting Rotation to Rocking Vibration by Guangxia Wang (1478734)

“…A series of <i>N</i>²,<i>N</i>⁶-bis­(triptycene-9-yl)­pyridine-2,6-dicarboxamides <b>1</b>–<b>4</b> were designed and synthesized. …”

Table_2_In vitro Neuroprotective Potential and Lipidomics Study of Olive Leaves Extracts Enriched in Triterpenoids.XLSX by Rocío Gallego (9723148)

“…Moreover, several triacylglycerols were found decreased. These results suggest triterpenoids from olive leaves as good neuroprotective candidates, and open a new gate for future experiments using in vivo models to corroborate this hypothesis.…”

Image_2_BTG2 suppresses renal cell carcinoma progression through N6-methyladenosine.tiff by Fuming Qi (14256764)

“…In this study, we confirm that BTG2 is frequently down-regulated in renal cell carcinoma (RCC) tissues and its low expression is associated with unfavorable prognosis and decreased m⁶A level. Moreover, we found that m⁶A methylation modifies the 5’UTR of BTG2 to promote its mRNA stability by binding to IGF2BP2. …”

Image_1_BTG2 suppresses renal cell carcinoma progression through N6-methyladenosine.tiff by Fuming Qi (14256764)

“…In this study, we confirm that BTG2 is frequently down-regulated in renal cell carcinoma (RCC) tissues and its low expression is associated with unfavorable prognosis and decreased m⁶A level. Moreover, we found that m⁶A methylation modifies the 5’UTR of BTG2 to promote its mRNA stability by binding to IGF2BP2. …”

Table_1_BTG2 suppresses renal cell carcinoma progression through N6-methyladenosine.xlsx by Fuming Qi (14256764)

“…In this study, we confirm that BTG2 is frequently down-regulated in renal cell carcinoma (RCC) tissues and its low expression is associated with unfavorable prognosis and decreased m⁶A level. Moreover, we found that m⁶A methylation modifies the 5’UTR of BTG2 to promote its mRNA stability by binding to IGF2BP2. …”

Image_1_Disulfiram Transcends ALDH Inhibitory Activity When Targeting Ovarian Cancer Tumor-Initiating Cells.jpeg by Michael W. Caminear (12252425)

“…<p>Epithelial ovarian cancer (EOC) is a global health burden and remains the fifth leading cause of cancer related death in women worldwide with the poorest five-year survival rate of the gynecological malignancies. …”

Image_1_RETRACTED: Extracellular Vesicles Carry lncRNA SNHG16 to Promote Metastasis of Breast Cancer Cells via the miR-892b/PPAPDC1A Axis.TIFF by Wenfei Xia (5055482)

“…The results showed that si-SNHG16 reduced the metastatic nodules and decreased the vimentin expression. In conclusion, EVs derived from BC cells transferred SNHG16 via the miR-892b/PPAPDC1A axis, thus promoting EMT, migration, and invasion of BC.…”

DataSheet_1_Collagen-I influences the post-translational regulation, binding partners and role of Annexin A2 in breast cancer progression.pdf by Amira F. Mahdi (12594904)

“…We then demonstrated that reducing Annexin A2 expression decreases the degradation of fibronectin by cancer cells and this effect on fibronectin turnover is increased according to collagen-I abundance.…”

DataSheet_1_BTG2 suppresses renal cell carcinoma progression through N6-methyladenosine.zip by Fuming Qi (14256764)

“…In this study, we confirm that BTG2 is frequently down-regulated in renal cell carcinoma (RCC) tissues and its low expression is associated with unfavorable prognosis and decreased m⁶A level. Moreover, we found that m⁶A methylation modifies the 5’UTR of BTG2 to promote its mRNA stability by binding to IGF2BP2. …”

Image_1_Extracellular Vesicles Carry lncRNA SNHG16 to Promote Metastasis of Breast Cancer Cells via the miR-892b/PPAPDC1A Axis.TIFF by Wenfei Xia (5055482)

“…The results showed that si-SNHG16 reduced the metastatic nodules and decreased the vimentin expression. In conclusion, EVs derived from BC cells transferred SNHG16 via the miR-892b/PPAPDC1A axis, thus promoting EMT, migration, and invasion of BC.…”

Robust <i>gdf9</i> and <i>bmp15</i> expression in the oocytes of ovotestes through the Figla-independent pathway in the hermaphroditic black porgy, <i>Acanthopagrus schlegelii</i> by Guan-Chung Wu (841217)

“…We observed that <i>gdf9</i> and <i>bmp15</i> expression was localized in the primary oocytes and gradually decreased after oocytes entered a secondary oocyte stage. …”

Image_1_Vitamin A Deficiency in the Early-Life Periods Alters a Diversity of the Colonic Mucosal Microbiota in Rats.TIF by Baolin Chen (8317047)

“…A metagenome analysis (LEfSe) and a differentially abundant features approach using Metastats for genus abundances revealed that Diaphorobacter and Psychrobacter were increased in the offspring persistent with VAD from embryonic stage (group B);Bifidobacterium was decreased and Staphylococcus was increased in the offspring with VAD after weaning (group C); Propionibacterium and Enterobacter were increased significantly in the offspring with VAD during gestation(group E); and Ochrobactrum was increased in group B and the offspring with VAD during gestation and lactation(group D). …”

Table_1_IL-37 Confers Anti-Tumor Activity by Regulation of m6A Methylation.xlsx by Xiaofeng Mu (3706156)

“…Interleukin 37 (IL-37) plays a crucial protective role in lung cancer. In our previous studies, we found that IL-37 is a potential novel tumor suppressor by inhibiting IL-6 expression to suppress STAT3 activation and decreasing epithelial-to-mesenchymal transition. …”

Image_1_IL-37 Confers Anti-Tumor Activity by Regulation of m6A Methylation.jpeg by Xiaofeng Mu (3706156)

“…Interleukin 37 (IL-37) plays a crucial protective role in lung cancer. In our previous studies, we found that IL-37 is a potential novel tumor suppressor by inhibiting IL-6 expression to suppress STAT3 activation and decreasing epithelial-to-mesenchymal transition. …”

Image_3_IL-37 Confers Anti-Tumor Activity by Regulation of m6A Methylation.jpeg by Xiaofeng Mu (3706156)

“…Interleukin 37 (IL-37) plays a crucial protective role in lung cancer. In our previous studies, we found that IL-37 is a potential novel tumor suppressor by inhibiting IL-6 expression to suppress STAT3 activation and decreasing epithelial-to-mesenchymal transition. …”

Image_2_IL-37 Confers Anti-Tumor Activity by Regulation of m6A Methylation.jpeg by Xiaofeng Mu (3706156)

“…Interleukin 37 (IL-37) plays a crucial protective role in lung cancer. In our previous studies, we found that IL-37 is a potential novel tumor suppressor by inhibiting IL-6 expression to suppress STAT3 activation and decreasing epithelial-to-mesenchymal transition. …”

Table_2_IL-37 Confers Anti-Tumor Activity by Regulation of m6A Methylation.xlsx by Xiaofeng Mu (3706156)

“…Interleukin 37 (IL-37) plays a crucial protective role in lung cancer. In our previous studies, we found that IL-37 is a potential novel tumor suppressor by inhibiting IL-6 expression to suppress STAT3 activation and decreasing epithelial-to-mesenchymal transition. …”